{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:16:39Z","timestamp":1793844999033,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"8045","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,1,9]]},"DOI":"10.1038\/s41586-024-08291-2","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:53:55Z","timestamp":1733943235000},"page":"412-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia"],"prefix":"10.1038","volume":"637","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8475-9206","authenticated-orcid":false,"given":"Kelsey L.","family":"Swingle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9810-5630","authenticated-orcid":false,"given":"Alex G.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C.","family":"Safford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C.","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-8893","authenticated-orcid":false,"given":"Ajay S.","family":"Thatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Palanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2124-351X","authenticated-orcid":false,"given":"Amanda M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6276-7502","authenticated-orcid":false,"given":"Emily L.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin J.","family":"Mukalel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0011-5222","authenticated-orcid":false,"given":"Xuexiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0795-6094","authenticated-orcid":false,"given":"Ryann A.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi A.","family":"Ghalsasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5672-6930","authenticated-orcid":false,"given":"Mohamad-Gabriel","family":"Alameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-2244","authenticated-orcid":false,"given":"Michael J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"8291_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. Pre-eclampsia. Lancet 398, 341\u2013354 (2021).","journal-title":"Lancet"},{"key":"8291_CR2","doi-asserted-by":"crossref","unstructured":"Swingle, K. L., Ricciardi, A. S., Peranteau, W. H. & Mitchell, M. J. Delivery technologies for women\u2019s health applications. Nat. Rev. Bioeng. 1, 408\u2013425 (2023).","DOI":"10.1038\/s44222-023-00040-w"},{"key":"8291_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. New Engl. J. Med. 379, 11\u201321 (2018).","journal-title":"New Engl. J. Med."},{"key":"8291_CR4","doi-asserted-by":"publisher","first-page":"2300852","DOI":"10.1002\/smll.202300852","volume":"20","author":"HC Geisler","year":"2023","unstructured":"Geisler, H. C., Safford, H. C. & Mitchell, M. J. Rational design of nanomedicine for placental disorders: birthing a new era in women\u2019s reproductive health. Small 20, 2300852 (2023).","journal-title":"Small"},{"key":"8291_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/HYPERTENSIONAHA.109.141937","volume":"55","author":"JS Gilbert","year":"2010","unstructured":"Gilbert, J. S. et al. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension. Hypertension 55, 380\u2013385 (2010).","journal-title":"Hypertension"},{"key":"8291_CR6","doi-asserted-by":"publisher","first-page":"H1781","DOI":"10.1152\/ajpheart.00373.2011","volume":"301","author":"J Mateus","year":"2011","unstructured":"Mateus, J. et al. Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1. Am. J. Physiol. Heart Circ. Physiol. 301, H1781\u2013H1787 (2011).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"8291_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","volume":"50","author":"Z Li","year":"2007","unstructured":"Li, Z. et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 50, 686\u2013692 (2007).","journal-title":"Hypertension"},{"key":"8291_CR8","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/gt.2008.102","volume":"15","author":"AL David","year":"2008","unstructured":"David, A. L. et al. Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Gene Ther. 15, 1344\u20131350 (2008).","journal-title":"Gene Ther."},{"key":"8291_CR9","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.placenta.2017.09.011","volume":"59","author":"AL David","year":"2017","unstructured":"David, A. L. Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction. Placenta 59, S44\u2013S50 (2017).","journal-title":"Placenta"},{"key":"8291_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/gt.2011.158","volume":"19","author":"V Mehta","year":"2012","unstructured":"Mehta, V. et al. Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A 165 in the uterine arteries of pregnant sheep. Gene Ther. 19, 925\u2013935 (2012).","journal-title":"Gene Ther."},{"key":"8291_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/hum.2013.214","volume":"25","author":"DJ Carr","year":"2014","unstructured":"Carr, D. J. et al. Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies. Hum. Gene Ther. 25, 375\u2013384 (2014).","journal-title":"Hum. Gene Ther."},{"key":"8291_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/HYPERTENSIONAHA.110.160242","volume":"57","author":"AK Woods","year":"2011","unstructured":"Woods, A. K. et al. Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH\/5 mice. Hypertension 57, 94\u2013102 (2011).","journal-title":"Hypertension"},{"key":"8291_CR13","doi-asserted-by":"crossref","unstructured":"Haase, N. et al. RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models. J. Clin. Invest. 130, 2928\u20132942 (2020).","DOI":"10.1172\/JCI99417"},{"key":"8291_CR14","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nbt.4297","volume":"36","author":"AA Turanov","year":"2018","unstructured":"Turanov, A. A. et al. RNAi modulation of placental sFLT1 for the treatment of preeclampsia. Nat. Biotechnol. 36, 1164\u20131173 (2018).","journal-title":"Nat. Biotechnol."},{"key":"8291_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrg3763","volume":"15","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15, 541\u2013555 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"8291_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.molmed.2021.03.003","volume":"27","author":"KL Swingle","year":"2021","unstructured":"Swingle, K. L., Hamilton, A. G. & Mitchell, M. J. Lipid nanoparticle-mediated delivery of mRNA therapeutics and vaccines. Trends Mol. Med. 27, 616\u2013617 (2021).","journal-title":"Trends Mol. Med."},{"key":"8291_CR17","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"P Polack Fernando","year":"2020","unstructured":"Polack Fernando, P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"New Engl. J. Med."},{"key":"8291_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"R Baden Lindsey","year":"2021","unstructured":"Baden Lindsey, R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"New Engl. J. Med."},{"key":"8291_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2020.03.006","volume":"322","author":"Y Sato","year":"2020","unstructured":"Sato, Y., Kinami, Y., Hashiba, K. & Harashima, H. Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E\/low density lipoprotein receptor and the N-acetyl-d-galactosamine\/asialoglycoprotein receptor pathway. J. Control. Release 322, 217\u2013226 (2020).","journal-title":"J. Control. Release"},{"key":"8291_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"8291_CR21","doi-asserted-by":"publisher","first-page":"e2109256118","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl Acad. Sci. USA 118, e2109256118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8291_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","volume":"345","author":"ST LoPresti","year":"2022","unstructured":"LoPresti, S. T., Arral, M. L., Chaudhary, N. & Whitehead, K. A. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs. J. Control. Release 345, 819\u2013831 (2022).","journal-title":"J. Control. Release"},{"key":"8291_CR23","doi-asserted-by":"publisher","unstructured":"Swingle, K. L. et al. Ionizable lipid nanoparticles for in vivo mRNA delivery to the placenta during pregnancy. J. Am. Chem. Soc. https:\/\/doi.org\/10.1021\/jacs.2c12893 (2023).","DOI":"10.1021\/jacs.2c12893"},{"key":"8291_CR24","first-page":"125","volume":"34","author":"RE Young","year":"2024","unstructured":"Young, R. E. et al. Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach. Bioact. Mater. 34, 125\u2013137 (2024).","journal-title":"Bioact. Mater."},{"key":"8291_CR25","doi-asserted-by":"publisher","first-page":"e2307810121","DOI":"10.1073\/pnas.2307810121","volume":"121","author":"N Chaudhary","year":"2024","unstructured":"Chaudhary, N. et al. Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes. Proc. Natl Acad. Sci. USA 121, e2307810121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8291_CR26","first-page":"e2303568","volume":"20","author":"HC Safford","year":"2024","unstructured":"Safford, H. C. et al. Orthogonal design of experiments for engineering of lipid nanoparticles for mRNA delivery to the placenta. Small 20, e2303568 (2024).","journal-title":"Small"},{"key":"8291_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jconrel.2024.05.036","volume":"371","author":"HC Geisler","year":"2024","unstructured":"Geisler, H. C. et al. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta. J. Control. Release 371, 455\u2013469 (2024).","journal-title":"J. Control. Release"},{"key":"8291_CR28","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","volume":"18","author":"K Paunovska","year":"2018","unstructured":"Paunovska, K. et al. A direct comparison of in vitro and in vivo nucleic acid selivery mediated by hundreds of nanoparticles reveals a weak correlation. Nano Lett. 18, 2148\u20132157 (2018).","journal-title":"Nano Lett."},{"key":"8291_CR29","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1073\/pnas.1620874114","volume":"114","author":"JE Dahlman","year":"2017","unstructured":"Dahlman, J. E. et al. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics. Proc. Natl Acad. Sci. USA 114, 2060\u20132065 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8291_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jconrel.2023.04.005","volume":"357","author":"SG Huayamares","year":"2023","unstructured":"Huayamares, S. G. et al. High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo. J. Control. Release 357, 394\u2013403 (2023).","journal-title":"J. Control. Release"},{"key":"8291_CR31","doi-asserted-by":"publisher","first-page":"2000111","DOI":"10.1002\/adtp.202000111","volume":"4","author":"R El-Mayta","year":"2021","unstructured":"El-Mayta, R. et al. A nanoparticle platform for accelerated in vivo oral delivery screening of nucleic acids. Adv. Ther. 4, 2000111 (2021).","journal-title":"Adv. Ther."},{"key":"8291_CR32","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1073\/pnas.0910603106","volume":"107","author":"KT Love","year":"2010","unstructured":"Love, K. T. et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl Acad. Sci. USA 107, 1864\u20131869 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8291_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nbt.1602","volume":"28","author":"SC Semple","year":"2010","unstructured":"Semple, S. C. et al. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 28, 172\u2013176 (2010).","journal-title":"Nat. Biotechnol."},{"key":"8291_CR34","doi-asserted-by":"publisher","first-page":"8657","DOI":"10.1002\/ange.201203263","volume":"124","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman, M. et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. 124, 8657\u20138661 (2012).","journal-title":"Angew. Chem."},{"key":"8291_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cca.2015.10.024","volume":"451","author":"LM Dusse","year":"2015","unstructured":"Dusse, L. M. et al. Revisiting HELLP syndrome. Clin. Chim. Acta 451, 117\u2013120 (2015).","journal-title":"Clin. Chim. Acta"},{"key":"8291_CR36","doi-asserted-by":"publisher","first-page":"1606944","DOI":"10.1002\/adma.201606944","volume":"29","author":"OS Fenton","year":"2017","unstructured":"Fenton, O. S. et al. Synthesis and biological evaluation of ionizable lipid materials for the in vivo delivery of messenger RNA to B lymphocytes. Adv. Mater. 29, 1606944 (2017).","journal-title":"Adv. Mater."},{"key":"8291_CR37","doi-asserted-by":"publisher","first-page":"9926","DOI":"10.1021\/jacs.2c02706","volume":"144","author":"L Xue","year":"2022","unstructured":"Xue, L. et al. Rational design of bisphosphonate lipid-like materials for mRNA delivery to the bone microenvironment. J. Am. Chem. Soc. 144, 9926\u20139937 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"8291_CR38","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","volume":"15","author":"KJ Kauffman","year":"2015","unstructured":"Kauffman, K. J. et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive Sscreening designs. Nano Lett. 15, 7300\u20137306 (2015).","journal-title":"Nano Lett."},{"key":"8291_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1021\/acs.nanolett.1c02503","volume":"22","author":"MM Billingsley","year":"2022","unstructured":"Billingsley, M. M. et al. Orthogonal design of experiments for optimization of lipid nanoparticles for mRNA engineering of CAR T cells. Nano Lett. 22, 533\u2013542 (2022).","journal-title":"Nano Lett."},{"key":"8291_CR40","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jconrel.2021.10.031","volume":"341","author":"KL Swingle","year":"2022","unstructured":"Swingle, K. L. et al. Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery. J. Control. Release 341, 616\u2013633 (2022).","journal-title":"J. Control. Release"},{"key":"8291_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06936-1","volume":"9","author":"N Veiga","year":"2018","unstructured":"Veiga, N. et al. Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes. Nat. Commun. 9, 4493 (2018).","journal-title":"Nat. Commun."},{"key":"8291_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","volume":"291","author":"H Parhiz","year":"2018","unstructured":"Parhiz, H. et al. PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake. J. Control. Release 291, 106\u2013115 (2018).","journal-title":"J. Control. Release"},{"key":"8291_CR43","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","volume":"23","author":"D Shi","year":"2023","unstructured":"Shi, D., Toyonaga, S. & Anderson, D. G. In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles. Nano Lett. 23, 2938\u20132944 (2023).","journal-title":"Nano Lett."},{"key":"8291_CR44","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda, L. et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science 381, 436\u2013443 (2023).","journal-title":"Science"},{"key":"8291_CR45","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis, P. R. & Hope, M. J. Lipid nanoparticle systems for enabling gene therapies. Mol. Ther. 25, 1467\u20131475 (2017).","journal-title":"Mol. Ther."},{"key":"8291_CR46","doi-asserted-by":"publisher","first-page":"102412","DOI":"10.1016\/j.nano.2021.102412","volume":"36","author":"NS Irvin-Choy","year":"2021","unstructured":"Irvin-Choy, N. S., Nelson, K. M., Dang, M. N., Gleghorn, J. P. & Day, E. S. Gold nanoparticle biodistribution in pregnant mice following intravenous administration varies with gestational age. Nanomed. Nanotechnol. Biol. Med. 36, 102412 (2021).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"8291_CR47","doi-asserted-by":"publisher","first-page":"e52273","DOI":"10.1371\/journal.pone.0052273","volume":"7","author":"T Raz","year":"2012","unstructured":"Raz, T. et al. The hemodynamic basis for positional- and inter-fetal dependent effects in dual arterial supply of mouse pregnancies. PLoS ONE 7, e52273 (2012).","journal-title":"PLoS ONE"},{"key":"8291_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/(SICI)1097-0029(19970701\/15)38:1\/2<52::AID-JEMT7>3.0.CO;2-W","volume":"38","author":"S Kertschanska","year":"1997","unstructured":"Kertschanska, S., Kosanke, G. & Kaufmann, P. Pressure dependence of so-called transtrophoblastic channels during fetal perfusion of human placental villi. Microsc. Res. Tech. 38, 52\u201362 (1997).","journal-title":"Microsc. Res. Tech."},{"key":"8291_CR49","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1053\/plac.2000.0558","volume":"21","author":"S Kertschanska","year":"2000","unstructured":"Kertschanska, S., Stulcov\u00e1, B., Kaufmann, P. & Stulc, J. Distensible transtrophoblastic channels in the rat placenta. Placenta 21, 670\u2013677 (2000).","journal-title":"Placenta"},{"key":"8291_CR50","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","volume":"31","author":"V Francia","year":"2020","unstructured":"Francia, V., Schiffelers, R. M., Cullis, P. R. & Witzigmann, D. The biomolecular corona of lipid nanoparticles for gene therapy. Bioconjug. Chem. 31, 2046\u20132059 (2020).","journal-title":"Bioconjug. Chem."},{"key":"8291_CR51","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1039\/D2LC00799A","volume":"23","author":"G Bashiri","year":"2023","unstructured":"Bashiri, G. et al. Nanoparticle protein corona: from structure and function to therapeutic targeting. Lab Chip 23, 1432\u20131466 (2023).","journal-title":"Lab Chip"},{"key":"8291_CR52","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","volume":"18","author":"A Akinc","year":"2010","unstructured":"Akinc, A. et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther. 18, 1357\u20131364 (2010).","journal-title":"Mol. Ther."},{"key":"8291_CR53","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0143-4004(97)80040-9","volume":"18","author":"LW Chamley","year":"1997","unstructured":"Chamley, L. W., Allen, J. L. & Johnson, P. M. Synthesis of \u03b22 glycoprotein 1 by the human placenta. Placenta 18, 403\u2013410 (1997).","journal-title":"Placenta"},{"key":"8291_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/molehr\/gah058","volume":"10","author":"SA Robertson","year":"2004","unstructured":"Robertson, S. A. et al. Effect of \u03b22\u2010glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody\u2010mediated pregnancy pathology in mice. Mol. Hum. Reprod. 10, 409\u2013416 (2004).","journal-title":"Mol. Hum. Reprod."},{"key":"8291_CR55","doi-asserted-by":"publisher","first-page":"681632","DOI":"10.3389\/fphys.2021.681632","volume":"12","author":"CA Waker","year":"2021","unstructured":"Waker, C. A., Kaufman, M. R. & Brown, T. L. Current state of preeclampsia mouse models: approaches, relevance, and standardization. Front. Physiol. 12, 681632 (2021).","journal-title":"Front. Physiol."},{"key":"8291_CR56","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.placenta.2015.10.014","volume":"36","author":"X Ding","year":"2015","unstructured":"Ding, X., Yang, Z., Han, Y. & Yu, H. Correlation of long-chain fatty acid oxidation with oxidative stress and inflammation in pre-eclampsia-like mouse models. Placenta 36, 1442\u20131449 (2015).","journal-title":"Placenta"},{"key":"8291_CR57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4103\/0366-6999.225058","volume":"131","author":"J Huai","year":"2018","unstructured":"Huai, J., Yang, Z., Yi, Y.-H. & Wang, G.-J. Different effects of pravastatin on preeclampsia-like symptoms in different mouse models. Chin. Med. J. (Engl.) 131, 461\u2013470 (2018).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"8291_CR58","doi-asserted-by":"publisher","unstructured":"Swingle, K. L., Hamilton, A. G. & Mitchell, M. J. Flow cytometric analysis of the murine placenta to evaluate nanoparticle platforms during pregnancy. Placenta https:\/\/doi.org\/10.1016\/j.placenta.2024.08.007 (2024).","DOI":"10.1016\/j.placenta.2024.08.007"},{"key":"8291_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10456-019-09694-w","volume":"23","author":"A Umapathy","year":"2020","unstructured":"Umapathy, A., Chamley, L. W. & James, J. L. Reconciling the distinct roles of angiogenic\/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies. Angiogenesis 23, 105\u2013117 (2020).","journal-title":"Angiogenesis"},{"key":"8291_CR60","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3389\/fimmu.2020.01864","volume":"11","author":"I Aneman","year":"2020","unstructured":"Aneman, I. et al. Mechanisms of key innate immune cells in early- and late-onset preeclampsia. Front. Immunol. 11, 1864 (2020).","journal-title":"Front. Immunol."},{"key":"8291_CR61","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/j.1582-4934.2009.00820.x","volume":"14","author":"A Bergmann","year":"2010","unstructured":"Bergmann, A. et al. Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J. Cell. Mol. Med. 14, 1857\u20131867 (2010).","journal-title":"J. Cell. Mol. Med."},{"key":"8291_CR62","doi-asserted-by":"publisher","first-page":"331ra40","DOI":"10.1126\/scitranslmed.aae0482","volume":"8","author":"H Wu","year":"2016","unstructured":"Wu, H. et al. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus. Sci. Transl. Med. 8, 331ra40 (2016).","journal-title":"Sci. Transl. Med."},{"key":"8291_CR63","doi-asserted-by":"publisher","first-page":"e3002105","DOI":"10.1371\/journal.pbio.3002105","volume":"21","author":"AG Hamilton","year":"2023","unstructured":"Hamilton, A. G., Swingle, K. L. & Mitchell, M. J. Biotechnology: overcoming biological barriers to nucleic acid delivery using lipid nanoparticles. PLoS Biol. 21, e3002105 (2023).","journal-title":"PLoS Biol."},{"key":"8291_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jconrel.2022.01.008","volume":"342","author":"Y Yan","year":"2022","unstructured":"Yan, Y. et al. Non-viral vectors for RNA delivery. J. Control. Release 342, 241\u2013279 (2022).","journal-title":"J. Control. Release"},{"key":"8291_CR65","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1515\/jpm-2021-0636","volume":"51","author":"V Stefanovic","year":"2023","unstructured":"Stefanovic, V. International Academy of Perinatal Medicine (IAPM) guidelines for screening, prediction, prevention and management of pre-eclampsia to reduce maternal mortality in developing countries. J. Perinat. Med. 51, 164\u2013169 (2023).","journal-title":"J. Perinat. Med."},{"key":"8291_CR66","doi-asserted-by":"crossref","unstructured":"Pardi, N., Muramatsu, H., Weissman, D. & Karik\u00f3, K. in Synthetic Messenger RNA and Cell Metabolism Modulation: Methods and Protocols Vol. 969 (ed. Rabinovich, P. M.) 29\u201342 (Humana, 2013).","DOI":"10.1007\/978-1-62703-260-5_2"},{"key":"8291_CR67","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833\u20131840 (2008).","journal-title":"Mol. Ther."},{"key":"8291_CR68","doi-asserted-by":"crossref","unstructured":"Weissman, D., Pardi, N., Muramatsu, H. & Karik\u00f3, K. in Synthetic Messenger RNA and Cell Metabolism Modulation: Methods and Protocols (ed. Rabinovich, P. M.) 43\u201354 (Humana, 2013).","DOI":"10.1007\/978-1-62703-260-5_3"},{"key":"8291_CR69","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1039\/D0BM01609H","volume":"9","author":"R Zhang","year":"2021","unstructured":"Zhang, R. et al. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver. Biomater. Sci. 9, 1449\u20131463 (2021).","journal-title":"Biomater. Sci."},{"key":"8291_CR70","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1021\/ja301621z","volume":"134","author":"D Chen","year":"2012","unstructured":"Chen, D. et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948\u20136951 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"8291_CR71","doi-asserted-by":"publisher","first-page":"1805097","DOI":"10.1002\/smll.201805097","volume":"15","author":"KA Hajj","year":"2019","unstructured":"Hajj, K. A. et al. Branched-tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pH. Small 15, 1805097 (2019).","journal-title":"Small"}],"updated-by":[{"DOI":"10.1038\/s41586-025-08605-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08291-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08291-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08291-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:02:41Z","timestamp":1773162161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08291-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":71,"journal-issue":{"issue":"8045","published-print":{"date-parts":[[2025,1,9]]}},"alternative-id":["8291"],"URL":"https:\/\/doi.org\/10.1038\/s41586-024-08291-2","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-025-08605-y","URL":"https:\/\/doi.org\/10.1038\/s41586-025-08605-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.L.S., H.C.S., H.C.G. and M.J.M. have filed a patent application based on this work. M.J.M. is an inventor on a patent related to this work filed by the Trustees of the University of Pennsylvania (PCT\/US20\/56252). D.W. is an inventor on several patents related to this work filed by the Trustees of the University of Pennsylvania (11\/990,646; 13\/ 585,517; 13\/839,023; 13\/839,155; 14\/456,302; 15\/339,363; 16\/299,202). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}